Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Identification of an allosteric site on the E3 ligase adapter cereblon

Abstract

Cereblon (CRBN) is the target of thalidomide derivatives 1 that achieve therapeutic efficacy against some haematologic neoplasias 2-4 by recruiting neosubstrates for degradation 5-7 . Despite the intense investigation of orthosteric thalidomide derivatives, little is known about alternate binding sites on CRBN. Here we report an evolutionarily conserved cryptic allosteric binding site on CRBN. Small-molecule SB-405483 binds the allosteric site to cooperatively enhance the binding of orthosteric ligands and alter their neosubstrate degradation profiles. A survey of over 100 orthosteric ligands and their degradation targets reveals trends in the classes of compounds and neosubstrates in which degradation outcomes are enhanced or inhibited by SB-405483. Structural investigations provide a mechanistic basis for the effects of the allosteric ligand by shifting the conformational distribution of CRBN open to a novel CRBN int and increasing the CRBN closed state. The discovery of a cryptic allosteric binding site on CRBN that alters the functional effects of orthosteric ligands opens new directions with broad implications for improving the selectivity and efficacy of CRBN therapeutics.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41586-025-09994-w

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 41 references

Cited by

See all 14

Metadata

Authors
Dippon, V. N., Rizvi, Z., Choudhry, A. E., Chung, C.-W., Alkuraya, I. F., Xu, W., Tao, X. B., Jurewicz, A. J., Schneck, J. L., Chen, W., Curnutt, N. M., Kabir, F., Chan, K.-H., Queisser, M. A., Musetti, C., Dai, H., Lander, G. C., Benowitz, A. B., & Woo, C. M.
Affiliations
  • Harvard University (US)
  • Scripps Research Institute (US)
  • GlaxoSmithKline (United States) (US)
  • GlaxoSmithKline Research & Development Limited (United Kingdom) (GB)
  • Bristol-Myers Squibb (United States) (US)
  • Broad Institute (US)
Corresponding author
  • Benowitz, Andrew B.
  • Woo, Christina M.
Venue
Nature
Published
2026-01-21
Volume
651
Issue
8105
Pages
482-490
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W7125107855
Cited by
14
References
41
Citations by year
2026: 14
FWCI
28.61
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of General Medical Sciences (R21GM154216, R01GM143805)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
Keywords
cereblon, allosteric site, E3 ubiquitin ligase, targeted protein degradation, thalidomide derivatives, protein conformational states
MeSH terms
Allosteric Regulation, Allosteric Site, Humans, Ligands, Models, Molecular, Peptide Hydrolases, Protein Binding, Thalidomide, Crystallography, X-Ray, Ubiquitin-Protein Ligases, Adaptor Proteins, Signal Transducing, Proteolysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of an allosteric site on the E3 ligase adapter cereblon. https://app.cochat.ai/papers/10.1038/s41586-025-09994-w
The paper
Dippon, V. N., Rizvi, Z., Choudhry, A. E., Chung, C.-W., Alkuraya, I. F., Xu, W., Tao, X. B., Jurewicz, A. J., Schneck, J. L., Chen, W., Curnutt, N. M., Kabir, F., Chan, K.-H., Queisser, M. A., Musetti, C., Dai, H., Lander, G. C., Benowitz, A. B., & Woo, C. M. (2026). Identification of an allosteric site on the E3 ligase adapter cereblon. Nature. https://doi.org/10.1038/s41586-025-09994-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.